1. Minimal hepatic encephalopathy may be present despite the absence of non-invasive and elastography evidence of cirrhosis in patients with primary biliary cholangitis
- Author
-
Jacek Janica, Andrzej Dabrowski, Jaroslaw Daniluk, Magdalena Rogalska – Plonska, Elzbieta Aleksiejuk, Pawel Rogalski, Stefania Antonowicz, and Dagmara Bogdanowska – Charkiewicz
- Subjects
Liver Cirrhosis ,medicine.medical_specialty ,Cirrhosis ,Chronic liver disease ,Gastroenterology ,Severity of Illness Index ,03 medical and health sciences ,Liver disease ,0302 clinical medicine ,Internal medicine ,medicine ,Humans ,030212 general & internal medicine ,Stage (cooking) ,Hepatic encephalopathy ,medicine.diagnostic_test ,business.industry ,Liver Cirrhosis, Biliary ,General Medicine ,Middle Aged ,medicine.disease ,030220 oncology & carcinogenesis ,Hepatic Encephalopathy ,Cohort ,Elasticity Imaging Techniques ,Elastography ,business ,Complication ,human activities - Abstract
Purpose Minimal hepatic encephalopathy (MHE) is an important complication of chronic liver disease (CLD); however, MHE burden in patients with primary biliary cholangitis (PBC) has not been determined yet. Therefore, our study aimed to assess the prevalence of MHE in a typical cohort of middle-aged, patients with PBC suspicion of liver fibrosis and to investigate the relationship between MHE, basic laboratory tests and the stage of liver fibrosis. Patients and methods Fifty-one patients (38 with PBC and 13 controls), were prospectively enrolled. Portosystemic Encephalopathy-Syndrome test was used to diagnose MHE. Elastography point qualification (ElastPQ) and non-invasive markers (APRI and FIB-4) were used to assess liver fibrosis. The severity of CLD was assessed using the Model of End-Stage Liver Disease (MELD) and Child-Pugh score. Results MHE was diagnosed in 9 patients (24.3%) with PBC and none in the control group. As many as 44.4% of the patients with MHE had neither advanced fibrosis nor cirrhosis, as demonstrated using non-invasive markers of liver fibrosis or ElastPQ. The MELD score was the only predictor of MHE with cut-off value 8.5 [AUC = 0.753, CI95% = 0.569 to 0.938)] with sensitivity of 56%, specificity of 85% and accuracy of the test of 78%. Non-invasive markers of liver fibrosis and ElastPQ did not predict MHE. Conclusions MHE may occur in PBC despite no evidence of advanced liver fibrosis or cirrhosis. The slightly elevated MELD score may indicate a substantially increased risk of MHE in patients with PBC.
- Published
- 2020